Last reviewed · How we verify
Systematic RAI-treatment
Systematic RAI-treatment involves the use of radioactive iodine to target and destroy thyroid cancer cells.
Systematic RAI-treatment involves the use of radioactive iodine to target and destroy thyroid cancer cells. Used for Thyroid cancer.
At a glance
| Generic name | Systematic RAI-treatment |
|---|---|
| Sponsor | Centre Francois Baclesse |
| Target | Thyroid cells |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
This process works by allowing the radioactive iodine to be taken up by the thyroid cells, which then absorb the radiation and die. The radioactive iodine is selectively taken up by the thyroid cells due to the presence of iodine transport mechanisms, allowing for targeted therapy with minimal damage to surrounding healthy tissues.
Approved indications
- Thyroid cancer
Common side effects
- Thyroiditis
- Salivary gland damage
- Hypothyroidism
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |